Hormone Therapy, Mental Health, and Quality of Life Among Transgender People: A Systematic Review

Abstract We sought to systematically review the effect of gender-affirming hormone therapy on psychological outcomes among transgender people. We searched PubMed, Embase, and PsycINFO through June 10, 2020 for studies evaluating quality of life (QOL), depression, anxiety, and death by suicide in the...

Full description

Saved in:
Bibliographic Details
Published inJournal of the Endocrine Society Vol. 5; no. 4; p. bvab011
Main Authors Baker, Kellan E, Wilson, Lisa M, Sharma, Ritu, Dukhanin, Vadim, McArthur, Kristen, Robinson, Karen A
Format Journal Article
LanguageEnglish
Published US Oxford University Press 01.04.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract We sought to systematically review the effect of gender-affirming hormone therapy on psychological outcomes among transgender people. We searched PubMed, Embase, and PsycINFO through June 10, 2020 for studies evaluating quality of life (QOL), depression, anxiety, and death by suicide in the context of gender-affirming hormone therapy among transgender people of any age. We excluded case studies and studies reporting on less than 3 months of follow-up. We included 20 studies reported in 22 publications. Fifteen were trials or prospective cohorts, one was a retrospective cohort, and 4 were cross-sectional. Seven assessed QOL, 12 assessed depression, 8 assessed anxiety, and 1 assessed death by suicide. Three studies included trans-feminine people only; 7 included trans-masculine people only, and 10 included both. Three studies focused on adolescents. Hormone therapy was associated with increased QOL, decreased depression, and decreased anxiety. Associations were similar across gender identity and age. Certainty in this conclusion is limited by high risk of bias in study designs, small sample sizes, and confounding with other interventions. We could not draw any conclusions about death by suicide. Future studies should investigate the psychological benefits of hormone therapy among larger and more diverse groups of transgender people using study designs that more effectively isolate the effects of hormone treatment.
AbstractList Abstract We sought to systematically review the effect of gender-affirming hormone therapy on psychological outcomes among transgender people. We searched PubMed, Embase, and PsycINFO through June 10, 2020 for studies evaluating quality of life (QOL), depression, anxiety, and death by suicide in the context of gender-affirming hormone therapy among transgender people of any age. We excluded case studies and studies reporting on less than 3 months of follow-up. We included 20 studies reported in 22 publications. Fifteen were trials or prospective cohorts, one was a retrospective cohort, and 4 were cross-sectional. Seven assessed QOL, 12 assessed depression, 8 assessed anxiety, and 1 assessed death by suicide. Three studies included trans-feminine people only; 7 included trans-masculine people only, and 10 included both. Three studies focused on adolescents. Hormone therapy was associated with increased QOL, decreased depression, and decreased anxiety. Associations were similar across gender identity and age. Certainty in this conclusion is limited by high risk of bias in study designs, small sample sizes, and confounding with other interventions. We could not draw any conclusions about death by suicide. Future studies should investigate the psychological benefits of hormone therapy among larger and more diverse groups of transgender people using study designs that more effectively isolate the effects of hormone treatment.
We sought to systematically review the effect of gender-affirming hormone therapy on psychological outcomes among transgender people. We searched PubMed, Embase, and PsycINFO through June 10, 2020 for studies evaluating quality of life (QOL), depression, anxiety, and death by suicide in the context of gender-affirming hormone therapy among transgender people of any age. We excluded case studies and studies reporting on less than 3 months of follow-up. We included 20 studies reported in 22 publications. Fifteen were trials or prospective cohorts, one was a retrospective cohort, and 4 were cross-sectional. Seven assessed QOL, 12 assessed depression, 8 assessed anxiety, and 1 assessed death by suicide. Three studies included trans-feminine people only; 7 included trans-masculine people only, and 10 included both. Three studies focused on adolescents. Hormone therapy was associated with increased QOL, decreased depression, and decreased anxiety. Associations were similar across gender identity and age. Certainty in this conclusion is limited by high risk of bias in study designs, small sample sizes, and confounding with other interventions. We could not draw any conclusions about death by suicide. Future studies should investigate the psychological benefits of hormone therapy among larger and more diverse groups of transgender people using study designs that more effectively isolate the effects of hormone treatment.
We sought to systematically review the effect of gender-affirming hormone therapy on psychological outcomes among transgender people. We searched PubMed, Embase, and PsycINFO through June 10, 2020 for studies evaluating quality of life (QOL), depression, anxiety, and death by suicide in the context of gender-affirming hormone therapy among transgender people of any age. We excluded case studies and studies reporting on less than 3 months of follow-up. We included 20 studies reported in 22 publications. Fifteen were trials or prospective cohorts, one was a retrospective cohort, and 4 were cross-sectional. Seven assessed QOL, 12 assessed depression, 8 assessed anxiety, and 1 assessed death by suicide. Three studies included trans-feminine people only; 7 included trans-masculine people only, and 10 included both. Three studies focused on adolescents. Hormone therapy was associated with increased QOL, decreased depression, and decreased anxiety. Associations were similar across gender identity and age. Certainty in this conclusion is limited by high risk of bias in study designs, small sample sizes, and confounding with other interventions. We could not draw any conclusions about death by suicide. Future studies should investigate the psychological benefits of hormone therapy among larger and more diverse groups of transgender people using study designs that more effectively isolate the effects of hormone treatment. Key Words: Transgender, hormone therapy, sex hormones, mental health, systematic review
Audience Academic
Author McArthur, Kristen
Robinson, Karen A
Baker, Kellan E
Sharma, Ritu
Dukhanin, Vadim
Wilson, Lisa M
AuthorAffiliation 3 Johns Hopkins Evidence-Based Practice Center , Baltimore, MD, USA
1 Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD, USA
2 Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, MD, USA
AuthorAffiliation_xml – name: 3 Johns Hopkins Evidence-Based Practice Center , Baltimore, MD, USA
– name: 1 Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD, USA
– name: 2 Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, MD, USA
Author_xml – sequence: 1
  givenname: Kellan E
  orcidid: 0000-0002-9716-7936
  surname: Baker
  fullname: Baker, Kellan E
  email: kbaker39@jhu.edu
– sequence: 2
  givenname: Lisa M
  surname: Wilson
  fullname: Wilson, Lisa M
– sequence: 3
  givenname: Ritu
  surname: Sharma
  fullname: Sharma, Ritu
– sequence: 4
  givenname: Vadim
  surname: Dukhanin
  fullname: Dukhanin, Vadim
– sequence: 5
  givenname: Kristen
  surname: McArthur
  fullname: McArthur, Kristen
– sequence: 6
  givenname: Karen A
  surname: Robinson
  fullname: Robinson, Karen A
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33644622$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1rGzEQxUVJaT6vPRZBLy3Eib525c2hYEITF1yatu5ZaKVZW0G72kq7Dv7vq2A3pBAoOkiMfvOYee8YHXShA4TeUnJBGSWX99DZFC7rja4Jpa_QEROSTWgl2cGz9yE6S-meEEIrLioh3qBDzkshSsaOkJ6H2GZVvFxD1P32HH-FbtAez0H7YX2OdWfx91F7N2xxaPDCNYBnuWOFl1F3aZVHgIjvIPQervAM_9ymAVo9OIN_wMbBwyl63Wif4Gx_n6BfN5-X1_PJ4tvtl-vZYmIEo8OkqYQ1lMlSClLWU1EYywivJfDS2KawUyILZhgQUjBODaOFrrXNLrCCWw6Sn6BPO91-rFuwJq8RtVd9dK2OWxW0U__-dG6tVmGj5LQSTFRZ4MNeIIbfI6RBtS4Z8F53EMakMiOmkgvBMvp-h660B-W6JmRF84irmZRF9lYSkamLF6h8LLTOZNMbl-svNZgYUorQPE1PiXpMXO0SV_vEc8O75zs_4X_zzcDHHRDG_n9ifwA1x7d2
CitedBy_id crossref_primary_10_1136_bmjopen_2022_067575
crossref_primary_10_1002_cpt_2234
crossref_primary_10_7326_M24_0636
crossref_primary_10_1016_j_eprac_2023_03_003
crossref_primary_10_7759_cureus_36484
crossref_primary_10_1056_NEJMp2106314
crossref_primary_10_1093_ofid_ofab404
crossref_primary_10_1007_s10508_024_02809_5
crossref_primary_10_47671_TVG_80_24_030
crossref_primary_10_1016_j_psyneuen_2023_106319
crossref_primary_10_1016_j_jsxm_2021_09_008
crossref_primary_10_1016_j_socscimed_2024_116681
crossref_primary_10_1080_0092623X_2022_2136117
crossref_primary_10_1016_j_jadohealth_2023_01_031
crossref_primary_10_1007_s10689_023_00341_4
crossref_primary_10_1016_j_jsxm_2022_03_603
crossref_primary_10_1016_j_cpr_2022_102229
crossref_primary_10_2174_1573401319666230530095256
crossref_primary_10_1136_archdischild_2023_326669
crossref_primary_10_1057_s41599_022_01291_5
crossref_primary_10_1590_0034_7167_2022_0183pt
crossref_primary_10_1055_a_2188_8898
crossref_primary_10_1080_26410397_2022_2045066
crossref_primary_10_1152_ajpheart_00346_2023
crossref_primary_10_1111_hiv_13677
crossref_primary_10_1080_13697137_2023_2176217
crossref_primary_10_1089_trgh_2021_0160
crossref_primary_10_1136_archdischild_2023_326670
crossref_primary_10_1016_j_acra_2023_10_037
crossref_primary_10_1186_s12991_023_00460_3
crossref_primary_10_1016_j_drugpo_2021_103366
crossref_primary_10_1093_pch_pxad087
crossref_primary_10_1093_jalm_jfae013
crossref_primary_10_1080_17437199_2024_2314506
crossref_primary_10_1089_trgh_2022_0165
crossref_primary_10_1080_26895269_2024_2323514
crossref_primary_10_1186_s13643_024_02566_5
crossref_primary_10_1097_HRP_0000000000000392
crossref_primary_10_1136_archdischild_2023_326681
crossref_primary_10_15585_mmwr_su7301a6
crossref_primary_10_1177_20420188221083512
crossref_primary_10_1200_EDBK_397264
crossref_primary_10_1016_j_japh_2023_08_016
crossref_primary_10_15585_mmwr_su7301a4
crossref_primary_10_1038_s41443_021_00490_z
crossref_primary_10_1007_s11606_023_08531_7
crossref_primary_10_1177_15579883211062681
crossref_primary_10_1007_s00127_022_02359_y
crossref_primary_10_1192_bjo_2022_51
crossref_primary_10_1093_ajhp_zxad320
crossref_primary_10_1007_s11136_024_03664_6
crossref_primary_10_1007_s00787_024_02440_8
crossref_primary_10_1007_s10815_023_03013_5
crossref_primary_10_1245_s10434_024_15319_4
crossref_primary_10_3389_fendo_2024_1086158
crossref_primary_10_3390_biomedicines11030670
crossref_primary_10_1210_clinem_dgae226
crossref_primary_10_1590_0034_7167_2022_0183
crossref_primary_10_7326_M23_0704
crossref_primary_10_1186_s12879_021_06782_5
crossref_primary_10_1016_j_psychres_2021_114272
crossref_primary_10_1038_s41591_022_02082_w
crossref_primary_10_1001_jamanetworkopen_2024_11322
crossref_primary_10_1055_a_1891_8158
crossref_primary_10_37226_rcp_v8i1_8069
crossref_primary_10_1210_jendso_bvab105
crossref_primary_10_1016_j_cpha_2024_02_006
crossref_primary_10_1080_26895269_2024_2289318
crossref_primary_10_1136_archdischild_2023_326500
crossref_primary_10_1016_j_cpha_2024_02_005
crossref_primary_10_1016_j_medj_2021_04_025
crossref_primary_10_1001_jamanetworkopen_2023_31919
crossref_primary_10_1016_j_tips_2022_03_006
crossref_primary_10_3389_fgwh_2023_1126946
crossref_primary_10_1080_00207411_2022_2068319
crossref_primary_10_1146_annurev_publhealth_052620_100313
crossref_primary_10_3390_healthcare11050668
crossref_primary_10_1007_s11940_022_00728_1
crossref_primary_10_1177_26318318231189836
crossref_primary_10_1080_26895269_2023_2290132
crossref_primary_10_1089_trgh_2023_0177
crossref_primary_10_1146_annurev_med_020222_121106
crossref_primary_10_1080_26895269_2024_2333525
crossref_primary_10_3389_fnhum_2023_1303871
crossref_primary_10_1016_j_esxm_2022_100533
crossref_primary_10_1080_0092623X_2023_2300828
crossref_primary_10_1080_10345329_2023_2231112
crossref_primary_10_1136_bmj_p382
crossref_primary_10_1136_bmj_p1877
crossref_primary_10_1080_13691058_2024_2358099
crossref_primary_10_1016_j_asmr_2023_04_019
crossref_primary_10_1080_00918369_2023_2186759
crossref_primary_10_3390_ijerph19020869
crossref_primary_10_1038_s41562_023_01605_w
crossref_primary_10_1891_LGBTQ_2020_0019
crossref_primary_10_1111_jpm_12933
crossref_primary_10_1136_archdischild_2023_326760
crossref_primary_10_1080_0092623X_2022_2070565
crossref_primary_10_1080_26895269_2022_2100644
crossref_primary_10_3390_healthcare11030379
crossref_primary_10_1089_trgh_2021_0139
crossref_primary_10_1093_abm_kaad035
crossref_primary_10_1051_medsci_2022151
crossref_primary_10_1080_15313204_2024_2338384
crossref_primary_10_1016_j_lana_2023_100568
crossref_primary_10_1089_lgbt_2023_0418
crossref_primary_10_21886_2219_8075_2022_13_3_83_92
Cites_doi 10.1016/S0140-6736(16)00682-6
10.1136/bmj.i4919
10.1037/a0037599
10.1016/j.jclinepi.2014.11.023
10.1016/j.euroneuro.2014.11.019
10.1186/s13633-020-00078-2
10.1371/journal.pone.0221583
10.1080/15532739.2011.700873
10.1016/j.psyneuen.2013.09.029
10.1016/j.psychres.2019.03.053
10.1080/15532739.2014.899174
10.1046/j.1365-2265.1997.2601068.x
10.1530/EJE-10-1038
10.1002/(SICI)1099-1557(199705)6:3<169::AID-PDS263>3.0.CO;2-3
10.1016/0026-0495(89)90233-3
10.1136/bmj.b2535
10.1111/jsm.12363
10.1016/j.jsxm.2016.02.001
10.1210/jc.2016-1276
10.1210/jc.2017-01658
10.11124/JBISRIR-2017-003869
10.1016/S2215-0366(16)30165-1
10.1080/0092623X.2012.736920
10.1186/s12888-017-1423-y
10.1097/NMD.0000000000000046
10.1080/00223890802108022
10.1007/s10508-018-1189-4
10.1016/j.jsxm.2018.03.079
10.1080/15532739.2015.1039176
10.1016/S2213-8587(18)30305-X
10.1136/bmj.l4898
10.1111/j.1365-2265.2009.03625.x
10.1542/peds.2013-2958
10.1089/trgh.2015.0008
10.1097/00005053-198011000-00009
10.5603/EP.2015.0008
10.1016/j.jsxm.2017.11.004
10.1111/acps.13164
10.1016/j.psyneuen.2011.08.010
10.1111/jsm.12698
10.1111/cen.13050
10.1080/15532739.2017.1314796
10.1176/appi.books.9780890425596
10.1016/j.anpedi.2020.01.019
10.1016/j.ecl.2019.01.001
10.1530/EJE-07-0511
10.1080/19317611.2013.833152
10.1080/19359705.2011.581195
10.1111/j.1743-6109.2011.02348.x
10.1007/s11136-006-0002-3
10.1111/j.1743-6109.2010.01943.x
10.1111/j.1743-6109.2011.02564.x
10.1177/0022167817745217
10.2147/NDT.S95310
10.1080/13691058.2014.950982
10.1111/cen.13821
10.1007/s11154-018-9459-y
ContentType Journal Article
Copyright The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. 2021
The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society.
COPYRIGHT 2021 Oxford University Press
Copyright_xml – notice: The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. 2021
– notice: The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society.
– notice: COPYRIGHT 2021 Oxford University Press
DBID TOX
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1210/jendso/bvab011
DatabaseName Oxford Open (Open Access)
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
PubMed



CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: TOX
  name: Oxford University Press Open Access
  url: https://academic.oup.com/journals/
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2472-1972
EndPage bvab011
ExternalDocumentID A775446704
10_1210_jendso_bvab011
33644622
10.1210/jendso/bvab011
Genre Journal Article
Review
GrantInformation_xml – fundername: ;
GroupedDBID 0R~
53G
AAFWJ
AAPPN
AAPXW
AAVAP
ABPTD
ABXVV
ACGFS
ADBBV
AENZO
AFPKN
AFULF
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAYMD
BCNDV
BTTYL
EBS
EJD
EMOBN
GROUPED_DOAJ
H13
HYE
IAO
KQ8
KSI
ML0
M~E
O9-
OK1
ROX
RPM
TJX
TOX
ABEJV
ITC
NPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c421t-f94dc12767406b845cd203b7e36cdf5d80752c2e005231c215abad210253d3e73
IEDL.DBID RPM
ISSN 2472-1972
IngestDate Tue Sep 17 21:07:22 EDT 2024
Fri Dec 06 00:16:14 EST 2024
Tue Nov 19 21:46:18 EST 2024
Tue Nov 12 23:50:37 EST 2024
Fri Dec 06 01:15:33 EST 2024
Sat Nov 02 12:25:43 EDT 2024
Wed Aug 28 03:17:16 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Transgender
hormone therapy
sex hormones
systematic review
mental health
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society.
http://creativecommons.org/licenses/by-nc-nd/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c421t-f94dc12767406b845cd203b7e36cdf5d80752c2e005231c215abad210253d3e73
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ORCID 0000-0002-9716-7936
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894249/
PMID 33644622
PQID 2494873442
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7894249
proquest_miscellaneous_2494873442
gale_infotracmisc_A775446704
gale_infotracacademiconefile_A775446704
crossref_primary_10_1210_jendso_bvab011
pubmed_primary_33644622
oup_primary_10_1210_jendso_bvab011
PublicationCentury 2000
PublicationDate 2021-04-01
PublicationDateYYYYMMDD 2021-04-01
PublicationDate_xml – month: 04
  year: 2021
  text: 2021-04-01
  day: 01
PublicationDecade 2020
PublicationPlace US
PublicationPlace_xml – name: US
– name: United States
PublicationTitle Journal of the Endocrine Society
PublicationTitleAlternate J Endocr Soc
PublicationYear 2021
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References van Kesteren (2021022011481483000_CIT0064) 1997; 47
Sterne (2021022011481483000_CIT0024) 2019; 366
Wierckx (2021022011481483000_CIT0048) 2011; 8
Heylens (2021022011481483000_CIT0053) 2014; 11
Warmuz-Stangierska (2021022011481483000_CIT0058) 2015; 66
Pelusi (2021022011481483000_CIT0027) 2014; 11
Fuss (2021022011481483000_CIT0037) 2015; 25
Defreyne (2021022011481483000_CIT0033) 2018; 15
Davis (2021022011481483000_CIT0060) 2014; 26
Sharma (2021022011481483000_CIT0018)
Metzger (2021022011481483000_CIT0040) 2019; 276
Wiepjes (2021022011481483000_CIT0065) 2020; 141
Robles (2021022011481483000_CIT0010) 2016; 3
Newfield (2021022011481483000_CIT0062) 2006; 15
Rohatgi (2021022011481483000_CIT0023) 2020
Thompson (2021022011481483000_CIT0051) 2015; 16
Oda (2021022011481483000_CIT0056) 2017; 17
Collin (2021022011481483000_CIT0001) 2016; 13
de Vries (2021022011481483000_CIT0035) 2014; 134
Colton Meier (2021022011481483000_CIT0059) 2011; 15
Elaut (2021022011481483000_CIT0057) 2008; 158
Murad (2021022011481483000_CIT0012) 2010; 72
Asscheman (2021022011481483000_CIT0044) 2011; 164
James (2021022011481483000_CIT0005) 2016
Baker (2021022011481483000_CIT0020); V1
Colizzi (2021022011481483000_CIT0031) 2014; 39
Schulz (2021022011481483000_CIT0008) 2018; 58
American Psychiatric Association (2021022011481483000_CIT0009) 2013
Ware (2021022011481483000_CIT0022) 1995; 33
Nobili (2021022011481483000_CIT0015) 2018; 19
Berkman (2021022011481483000_CIT0026) 2015; 68
Wylie (2021022011481483000_CIT0007) 2016; 388
Gava (2021022011481483000_CIT0029) 2018; 89
Motta (2021022011481483000_CIT0041) 2018; 15
Turan (2021022011481483000_CIT0042) 2018; 47
Costantino (2021022011481483000_CIT0032) 2013; 39
Mahfouda (2021022011481483000_CIT0017) 2019; 7
Keo-Meier (2021022011481483000_CIT0061) 2015; 83
Gómez-Gil (2021022011481483000_CIT0055) 2008; 90
Costa (2021022011481483000_CIT0014) 2016; 12
Sterne (2021022011481483000_CIT0025) 2016; 355
López de Lara (2021022011481483000_CIT0038) 2020; 93
Goodman (2021022011481483000_CIT0002) 2019; 48
Arístegui (2021022011481483000_CIT0011) 2017; 18
Gómez-Gil (2021022011481483000_CIT0045) 2012; 37
Leavitt (2021022011481483000_CIT0047) 1980; 168
Deutsch (2021022011481483000_CIT0006) 2016
Webb (2021022011481483000_CIT0052) 2016
Moher (2021022011481483000_CIT0019) 2009; 339
Achille (2021022011481483000_CIT0030) 2020; 2020
Hembree (2021022011481483000_CIT0004) 2017; 102
Fisher (2021022011481483000_CIT0036) 2016; 101
(2021022011481483000_CIT0021) 2020
Gooren (2021022011481483000_CIT0063) 2015; 17
Asscheman (2021022011481483000_CIT0043) 1989; 38
Gorin-Lazard (2021022011481483000_CIT0054) 2013; 201
White Hughto (2021022011481483000_CIT0013) 2016; 1
de Vries (2021022011481483000_CIT0034) 2011; 8
Coleman (2021022011481483000_CIT0003) 2012; 13
Gava (2021022011481483000_CIT0028) 2016; 85
Manieri (2021022011481483000_CIT0039) 2014; 15
Rowniak (2021022011481483000_CIT0016) 2019; 17
Gorin-Lazard (2021022011481483000_CIT0046) 2012; 9
Reisner (2021022011481483000_CIT0050) 2019; 14
Heinemann (2021022011481483000_CIT0049) 1997; 6
References_xml – volume: 388
  start-page: 401
  issue: 10042
  year: 2016
  ident: 2021022011481483000_CIT0007
  article-title: Serving transgender people: clinical care considerations and service delivery models in transgender health
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(16)00682-6
  contributor:
    fullname: Wylie
– volume: 355
  start-page: i4919
  year: 2016
  ident: 2021022011481483000_CIT0025
  article-title: ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
  publication-title: BMJ.
  doi: 10.1136/bmj.i4919
  contributor:
    fullname: Sterne
– volume: 83
  start-page: 143
  issue: 1
  year: 2015
  ident: 2021022011481483000_CIT0061
  article-title: Testosterone treatment and MMPI-2 improvement in transgender men: a prospective controlled study
  publication-title: J Consult Clin Psychol.
  doi: 10.1037/a0037599
  contributor:
    fullname: Keo-Meier
– volume: 68
  start-page: 1312
  issue: 11
  year: 2015
  ident: 2021022011481483000_CIT0026
  article-title: Grading the strength of a body of evidence when assessing health care interventions: an EPC update
  publication-title: J Clin Epidemiol.
  doi: 10.1016/j.jclinepi.2014.11.023
  contributor:
    fullname: Berkman
– volume: 25
  start-page: 95
  issue: 1
  year: 2015
  ident: 2021022011481483000_CIT0037
  article-title: Cross-sex hormone treatment in male-to-female transsexual persons reduces serum brain-derived neurotrophic factor (BDNF)
  publication-title: Eur Neuropsychopharmacol.
  doi: 10.1016/j.euroneuro.2014.11.019
  contributor:
    fullname: Fuss
– volume: 2020
  start-page: 8
  year: 2020
  ident: 2021022011481483000_CIT0030
  article-title: Longitudinal impact of gender-affirming endocrine intervention on the mental health and well-being of transgender youths: preliminary results
  publication-title: Int J Pediatr Endocrinol.
  doi: 10.1186/s13633-020-00078-2
  contributor:
    fullname: Achille
– volume: 14
  start-page: e0221583
  issue: 8
  year: 2019
  ident: 2021022011481483000_CIT0050
  article-title: Comparing the health of non-binary and binary transgender adults in a statewide non-probability sample
  publication-title: Plos One.
  doi: 10.1371/journal.pone.0221583
  contributor:
    fullname: Reisner
– volume: 13
  start-page: 165
  issue: 4
  year: 2012
  ident: 2021022011481483000_CIT0003
  article-title: Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7
  publication-title: Int J Transgenderism.
  doi: 10.1080/15532739.2011.700873
  contributor:
    fullname: Coleman
– volume: 39
  start-page: 65
  year: 2014
  ident: 2021022011481483000_CIT0031
  article-title: Transsexual patients’ psychiatric comorbidity and positive effect of cross-sex hormonal treatment on mental health: results from a longitudinal study
  publication-title: Psychoneuroendocrinology.
  doi: 10.1016/j.psyneuen.2013.09.029
  contributor:
    fullname: Colizzi
– volume: 276
  start-page: 31
  year: 2019
  ident: 2021022011481483000_CIT0040
  article-title: The effect of testosterone therapy on personality traits of trans men: a controlled prospective study in Germany and Switzerland
  publication-title: Psychiatry Res.
  doi: 10.1016/j.psychres.2019.03.053
  contributor:
    fullname: Metzger
– volume: 15
  start-page: 53
  issue: 2
  year: 2014
  ident: 2021022011481483000_CIT0039
  article-title: Medical treatment of subjects with gender identity disorder: the experience in an Italian Public Health Center
  publication-title: Int J Transgenderism.
  doi: 10.1080/15532739.2014.899174
  contributor:
    fullname: Manieri
– volume: 47
  start-page: 337
  issue: 3
  year: 1997
  ident: 2021022011481483000_CIT0064
  article-title: Mortality and morbidity in transsexual subjects treated with cross-sex hormones
  publication-title: Clin Endocrinol (Oxf).
  doi: 10.1046/j.1365-2265.1997.2601068.x
  contributor:
    fullname: van Kesteren
– volume: 164
  start-page: 635
  issue: 4
  year: 2011
  ident: 2021022011481483000_CIT0044
  article-title: A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones
  publication-title: Eur J Endocrinol.
  doi: 10.1530/EJE-10-1038
  contributor:
    fullname: Asscheman
– volume: 6
  start-page: 169
  issue: 3
  year: 1997
  ident: 2021022011481483000_CIT0049
  article-title: Safety of cyproterone acetate: report of active surveillance
  publication-title: Pharmacoepidemiol Drug Saf.
  doi: 10.1002/(SICI)1099-1557(199705)6:3<169::AID-PDS263>3.0.CO;2-3
  contributor:
    fullname: Heinemann
– volume: V1
  ident: 2021022011481483000_CIT0020
  article-title: Data associated with the publication: Hormone therapy, mental health, and quality of life among transgender people: a systematic review
  publication-title: Johns Hopkins Univ Data Arch.
  contributor:
    fullname: Baker
– volume: 38
  start-page: 869
  issue: 9
  year: 1989
  ident: 2021022011481483000_CIT0043
  article-title: Mortality and morbidity in transsexual patients with cross-gender hormone treatment
  publication-title: Metabolism.
  doi: 10.1016/0026-0495(89)90233-3
  contributor:
    fullname: Asscheman
– volume: 339
  start-page: b2535
  year: 2009
  ident: 2021022011481483000_CIT0019
  article-title: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
  publication-title: BMJ.
  doi: 10.1136/bmj.b2535
  contributor:
    fullname: Moher
– volume: 11
  start-page: 119
  issue: 1
  year: 2014
  ident: 2021022011481483000_CIT0053
  article-title: Effects of different steps in gender reassignment therapy on psychopathology: a prospective study of persons with a gender identity disorder
  publication-title: J Sex Med.
  doi: 10.1111/jsm.12363
  contributor:
    fullname: Heylens
– ident: 2021022011481483000_CIT0018
  contributor:
    fullname: Sharma
– volume: 13
  start-page: 613
  issue: 4
  year: 2016
  ident: 2021022011481483000_CIT0001
  article-title: Prevalence of transgender depends on the “case” definition: a systematic review
  publication-title: J Sex Med.
  doi: 10.1016/j.jsxm.2016.02.001
  contributor:
    fullname: Collin
– volume: 101
  start-page: 4260
  issue: 11
  year: 2016
  ident: 2021022011481483000_CIT0036
  article-title: Cross-sex hormone treatment and psychobiological changes in transsexual persons: two-year follow-up data
  publication-title: J Clin Endocrinol Metab.
  doi: 10.1210/jc.2016-1276
  contributor:
    fullname: Fisher
– volume: 102
  start-page: 3869
  issue: 11
  year: 2017
  ident: 2021022011481483000_CIT0004
  article-title: Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society Clinical Practice Guideline
  publication-title: J Clin Endocrinol Metab.
  doi: 10.1210/jc.2017-01658
  contributor:
    fullname: Hembree
– volume: 17
  start-page: 1826
  issue: 9
  year: 2019
  ident: 2021022011481483000_CIT0016
  article-title: Effect of cross-sex hormones on the quality of life, depression and anxiety of transgender individuals: a quantitative systematic review
  publication-title: JBI Database System Rev Implement Rep.
  doi: 10.11124/JBISRIR-2017-003869
  contributor:
    fullname: Rowniak
– year: 2016
  ident: 2021022011481483000_CIT0006
  contributor:
    fullname: Deutsch
– volume: 3
  start-page: 850
  issue: 9
  year: 2016
  ident: 2021022011481483000_CIT0010
  article-title: Removing transgender identity from the classification of mental disorders: a Mexican field study for ICD-11
  publication-title: Lancet Psychiatry.
  doi: 10.1016/S2215-0366(16)30165-1
  contributor:
    fullname: Robles
– volume: 39
  start-page: 321
  issue: 4
  year: 2013
  ident: 2021022011481483000_CIT0032
  article-title: A prospective study on sexual function and mood in female-to-male transsexuals during testosterone administration and after sex reassignment surgery
  publication-title: J Sex Marital Ther.
  doi: 10.1080/0092623X.2012.736920
  contributor:
    fullname: Costantino
– volume: 17
  start-page: 256
  issue: 1
  year: 2017
  ident: 2021022011481483000_CIT0056
  article-title: Efficacy of hormonal and mental treatments with MMPI in FtM individuals: cross-sectional and longitudinal studies
  publication-title: BMC Psychiatry.
  doi: 10.1186/s12888-017-1423-y
  contributor:
    fullname: Oda
– volume: 201
  start-page: 996
  issue: 11
  year: 2013
  ident: 2021022011481483000_CIT0054
  article-title: Hormonal therapy is associated with better self-esteem, mood, and quality of life in transsexuals
  publication-title: J Nerv Ment Dis.
  doi: 10.1097/NMD.0000000000000046
  contributor:
    fullname: Gorin-Lazard
– volume: 90
  start-page: 368
  issue: 4
  year: 2008
  ident: 2021022011481483000_CIT0055
  article-title: MMPI-2 characteristics of transsexuals requesting sex reassignment: comparison of patients in prehormonal and presurgical phases
  publication-title: J Pers Assess.
  doi: 10.1080/00223890802108022
  contributor:
    fullname: Gómez-Gil
– volume: 47
  start-page: 2349
  issue: 8
  year: 2018
  ident: 2021022011481483000_CIT0042
  article-title: Alterations in body uneasiness, eating attitudes, and psychopathology before and after cross-sex hormonal treatment in patients with female-to-male gender dysphoria
  publication-title: Arch Sex Behav.
  doi: 10.1007/s10508-018-1189-4
  contributor:
    fullname: Turan
– volume: 15
  start-page: 768
  issue: 5
  year: 2018
  ident: 2021022011481483000_CIT0033
  article-title: Prospective evaluation of self-reported aggression in transgender persons
  publication-title: J Sex Med.
  doi: 10.1016/j.jsxm.2018.03.079
  contributor:
    fullname: Defreyne
– volume: 16
  start-page: 36
  issue: 1
  year: 2015
  ident: 2021022011481483000_CIT0051
  article-title: Quality-of-life measurement: assessing the WHOQOL-BREF scale in a sample of high-HIV-risk transgender women in San Francisco, California
  publication-title: Int J Transgend.
  doi: 10.1080/15532739.2015.1039176
  contributor:
    fullname: Thompson
– volume-title: The Report of the 2015 U.S. Transgender Survey
  year: 2016
  ident: 2021022011481483000_CIT0005
  contributor:
    fullname: James
– volume: 7
  start-page: 484
  issue: 6
  year: 2019
  ident: 2021022011481483000_CIT0017
  article-title: Gender-affirming hormones and surgery in transgender children and adolescents
  publication-title: Lancet Diabetes Endocrinol.
  doi: 10.1016/S2213-8587(18)30305-X
  contributor:
    fullname: Mahfouda
– volume: 366
  start-page: l4898
  year: 2019
  ident: 2021022011481483000_CIT0024
  article-title: RoB 2: a revised tool for assessing risk of bias in randomised trials
  publication-title: BMJ.
  doi: 10.1136/bmj.l4898
  contributor:
    fullname: Sterne
– volume: 72
  start-page: 214
  issue: 2
  year: 2010
  ident: 2021022011481483000_CIT0012
  article-title: Hormonal therapy and sex reassignment: a systematic review and meta-analysis of quality of life and psychosocial outcomes
  publication-title: Clin Endocrinol (Oxf).
  doi: 10.1111/j.1365-2265.2009.03625.x
  contributor:
    fullname: Murad
– volume: 134
  start-page: 696
  issue: 4
  year: 2014
  ident: 2021022011481483000_CIT0035
  article-title: Young adult psychological outcome after puberty suppression and gender reassignment
  publication-title: Pediatrics.
  doi: 10.1542/peds.2013-2958
  contributor:
    fullname: de Vries
– volume: 1
  start-page: 21
  issue: 1
  year: 2016
  ident: 2021022011481483000_CIT0013
  article-title: A systematic review of the effects of hormone therapy on psychological functioning and quality of life in transgender individuals
  publication-title: Transgend Health.
  doi: 10.1089/trgh.2015.0008
  contributor:
    fullname: White Hughto
– volume: 168
  start-page: 693
  issue: 11
  year: 1980
  ident: 2021022011481483000_CIT0047
  article-title: Presurgical adjustment in male transsexuals with and without hormonal treatment
  publication-title: J Nerv Ment Dis.
  doi: 10.1097/00005053-198011000-00009
  contributor:
    fullname: Leavitt
– volume: 66
  start-page: 47
  issue: 1
  year: 2015
  ident: 2021022011481483000_CIT0058
  article-title: Emotional functions in transsexuals after the first step in physical transformation
  publication-title: Endokrynol Pol.
  doi: 10.5603/EP.2015.0008
  contributor:
    fullname: Warmuz-Stangierska
– volume: 15
  start-page: 94
  issue: 1
  year: 2018
  ident: 2021022011481483000_CIT0041
  article-title: Does testosterone treatment increase anger expression in a population of transgender men?
  publication-title: J Sex Med.
  doi: 10.1016/j.jsxm.2017.11.004
  contributor:
    fullname: Motta
– volume: 141
  start-page: 486
  issue: 6
  year: 2020
  ident: 2021022011481483000_CIT0065
  article-title: Trends in suicide death risk in transgender people: results from the Amsterdam Cohort of Gender Dysphoria study (1972-2017)
  publication-title: Acta Psychiatr Scand.
  doi: 10.1111/acps.13164
  contributor:
    fullname: Wiepjes
– year: 2020
  ident: 2021022011481483000_CIT0023
  contributor:
    fullname: Rohatgi
– year: 2016
  ident: 2021022011481483000_CIT0052
  contributor:
    fullname: Webb
– volume: 37
  start-page: 662
  issue: 5
  year: 2012
  ident: 2021022011481483000_CIT0045
  article-title: Hormone-treated transsexuals report less social distress, anxiety and depression
  publication-title: Psychoneuroendocrinology.
  doi: 10.1016/j.psyneuen.2011.08.010
  contributor:
    fullname: Gómez-Gil
– volume: 11
  start-page: 3002
  issue: 12
  year: 2014
  ident: 2021022011481483000_CIT0027
  article-title: Effects of three different testosterone formulations in female-to-male transsexual persons
  publication-title: J Sex Med.
  doi: 10.1111/jsm.12698
  contributor:
    fullname: Pelusi
– volume: 85
  start-page: 239
  issue: 2
  year: 2016
  ident: 2021022011481483000_CIT0028
  article-title: Cyproterone acetate vs leuprolide acetate in combination with transdermal oestradiol in transwomen: a comparison of safety and effectiveness
  publication-title: Clin Endocrinol (Oxf).
  doi: 10.1111/cen.13050
  contributor:
    fullname: Gava
– volume: 18
  start-page: 446
  issue: 4
  year: 2017
  ident: 2021022011481483000_CIT0011
  article-title: Impact of the Gender Identity Law in Argentinean transgender women
  publication-title: Int J Transgenderism.
  doi: 10.1080/15532739.2017.1314796
  contributor:
    fullname: Arístegui
– volume-title: Diagnostic and Statistical Manual of Mental Disorders
  year: 2013
  ident: 2021022011481483000_CIT0009
  doi: 10.1176/appi.books.9780890425596
  contributor:
    fullname: American Psychiatric Association
– volume: 93
  start-page: 41
  issue: 1
  year: 2020
  ident: 2021022011481483000_CIT0038
  article-title: Evaluación psicosocial en adolescentes transgénero
  publication-title: An Pediatría.
  doi: 10.1016/j.anpedi.2020.01.019
  contributor:
    fullname: López de Lara
– volume: 48
  start-page: 303
  issue: 2
  year: 2019
  ident: 2021022011481483000_CIT0002
  article-title: Size and distribution of transgender and gender nonconforming populations: a narrative review
  publication-title: Endocrinol Metab Clin North Am.
  doi: 10.1016/j.ecl.2019.01.001
  contributor:
    fullname: Goodman
– volume: 158
  start-page: 393
  issue: 3
  year: 2008
  ident: 2021022011481483000_CIT0057
  article-title: Hypoactive sexual desire in transsexual women: prevalence and association with testosterone levels
  publication-title: Eur J Endocrinol.
  doi: 10.1530/EJE-07-0511
  contributor:
    fullname: Elaut
– volume: 26
  start-page: 113
  issue: 2
  year: 2014
  ident: 2021022011481483000_CIT0060
  article-title: Effects of testosterone treatment and chest reconstruction surgery on mental health and sexuality in female-to-male transgender people
  publication-title: Int J Sex Health.
  doi: 10.1080/19317611.2013.833152
  contributor:
    fullname: Davis
– volume: 15
  start-page: 281
  issue: 3
  year: 2011
  ident: 2021022011481483000_CIT0059
  article-title: The effects of hormonal gender affirmation treatment on mental health in female-to-male transsexuals
  publication-title: J Gay Lesbian Ment Health.
  doi: 10.1080/19359705.2011.581195
  contributor:
    fullname: Colton Meier
– volume: 8
  start-page: 3379
  issue: 12
  year: 2011
  ident: 2021022011481483000_CIT0048
  article-title: Quality of life and sexual health after sex reassignment surgery in transsexual men
  publication-title: J Sex Med.
  doi: 10.1111/j.1743-6109.2011.02348.x
  contributor:
    fullname: Wierckx
– volume: 15
  start-page: 1447
  issue: 9
  year: 2006
  ident: 2021022011481483000_CIT0062
  article-title: Female-to-male transgender quality of life
  publication-title: Qual Life Res.
  doi: 10.1007/s11136-006-0002-3
  contributor:
    fullname: Newfield
– volume: 8
  start-page: 2276
  issue: 8
  year: 2011
  ident: 2021022011481483000_CIT0034
  article-title: Puberty suppression in adolescents with gender identity disorder: a prospective follow-up study
  publication-title: J Sex Med.
  doi: 10.1111/j.1743-6109.2010.01943.x
  contributor:
    fullname: de Vries
– volume: 9
  start-page: 531
  issue: 2
  year: 2012
  ident: 2021022011481483000_CIT0046
  article-title: Is hormonal therapy associated with better quality of life in transsexuals? A cross-sectional study
  publication-title: J Sex Med.
  doi: 10.1111/j.1743-6109.2011.02564.x
  contributor:
    fullname: Gorin-Lazard
– volume: 58
  start-page: 72
  issue: 1
  year: 2018
  ident: 2021022011481483000_CIT0008
  article-title: The informed consent model of transgender care: an alternative to the diagnosis of gender dysphoria
  publication-title: J Humanist Psychol.
  doi: 10.1177/0022167817745217
  contributor:
    fullname: Schulz
– volume: 12
  start-page: 1953
  year: 2016
  ident: 2021022011481483000_CIT0014
  article-title: The effect of cross-sex hormonal treatment on gender dysphoria individuals’ mental health: a systematic review
  publication-title: Neuropsychiatr Dis Treat.
  doi: 10.2147/NDT.S95310
  contributor:
    fullname: Costa
– volume: 33
  start-page: AS264
  issue: 4 Suppl
  year: 1995
  ident: 2021022011481483000_CIT0022
  article-title: Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study
  publication-title: Med Care.
  contributor:
    fullname: Ware
– volume: 17
  start-page: 92
  issue: 1
  year: 2015
  ident: 2021022011481483000_CIT0063
  article-title: Cross-sex hormone use, functional health and mental well-being among transgender men (Toms) and Transgender Women (Kathoeys) in Thailand
  publication-title: Cult Health Sex.
  doi: 10.1080/13691058.2014.950982
  contributor:
    fullname: Gooren
– volume-title: Evidence Partners
  year: 2020
  ident: 2021022011481483000_CIT0021
– volume: 89
  start-page: 878
  issue: 6
  year: 2018
  ident: 2021022011481483000_CIT0029
  article-title: Testosterone undecanoate and testosterone enanthate injections are both effective and safe in transmen over 5 years of administration
  publication-title: Clin Endocrinol (Oxf).
  doi: 10.1111/cen.13821
  contributor:
    fullname: Gava
– volume: 19
  start-page: 199
  issue: 3
  year: 2018
  ident: 2021022011481483000_CIT0015
  article-title: Quality of life of treatment-seeking transgender adults: a systematic review and meta-analysis
  publication-title: Rev Endocr Metab Disord.
  doi: 10.1007/s11154-018-9459-y
  contributor:
    fullname: Nobili
SSID ssj0001934944
Score 2.5632524
SecondaryResourceType review_article
Snippet Abstract We sought to systematically review the effect of gender-affirming hormone therapy on psychological outcomes among transgender people. We searched...
We sought to systematically review the effect of gender-affirming hormone therapy on psychological outcomes among transgender people. We searched PubMed,...
SourceID pubmedcentral
proquest
gale
crossref
pubmed
oup
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage bvab011
SubjectTerms Anxiety
Case studies
Conjugated estrogens
Gender identity
Mental health
Meta-Analysis
Psychological research
Transgender people
Title Hormone Therapy, Mental Health, and Quality of Life Among Transgender People: A Systematic Review
URI https://www.ncbi.nlm.nih.gov/pubmed/33644622
https://search.proquest.com/docview/2494873442
https://pubmed.ncbi.nlm.nih.gov/PMC7894249
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LTxsxEB4BB8Slailt0wIyVaVeWJLY3vUutwiBItS0SAQpt5VfC0Flg9qAxL_vjL0bZXup1Mte_JRnvDNjf_MZ4Eul0xzNtkiqTGOAoiVPCuV1krk817nTRWEoUXjyPRvfyMtZOtuAtM2FCaB9a-Yn9c-Hk3p-F7CVjw-23-LE-leTM5UXEsOG_iZsKp6vhejhYKUgxhXZEDRShso9gUsXffOsDWrzDmwLgV5AxnnHFjV_5E6a25q3-Tdocs0KXbyGV437yEZxmm9gw9e7sD1pLsjfgh6jD7qoPZtGtoBjFkl6WEw3Oma6dizyZrywRcW-zSvPRvTgEAtW6za8LMeuAq78lI3Y9YrpmcVrhD24uTifno2T5hWFxEo-XCZVIZ0dciLtGWQml6l1fCCM8iKzrkodsRFzy304IB5adAG00Y4iwVQ44ZV4B1s1TvwDMKPQecoMV0WOgRVGhqKwDrvzemBSI4c9-NquZ_kYyTJKCjKwszIKoWyEgDVpuUvaRbiaVjfJADgO8VGVo0DMl6mB7MF-pyZqv-0Uf0aB_XO0o1aeJbUnXFntF0-_S07sOEpIyXvwPsp31VerJT1QHcmvKhAzd7cEFTYwdDcK-vG_W36CHU7gmQAR2oet5a8nf4Dez9IchlODw6Dz-J3-mP0BVW8HkQ
link.rule.ids 230,315,728,781,785,865,886,27929,27930,53796,53798
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxEB6VIpVeEM8SKGAQEpduk9hee80tqqgCJFUlUqk3y6-FILqpIEXi3zO2d6MsFyTOtseWZ3Znxv7mM8Cb2pQVum1W1MJggmI4LZQMphC-qkzljVI2FgrPz8T0gn-8LC93oOxqYRJo39nlcfP96rhZfk3YyusrN-xwYsPz-YmsFMe0YXgLbpdMKrGVpKejFRU5V3hL0RhrVL5FeOlqaH8Zi_a8D3uMYRwgKO15o_af3Ct024o3_4ZNbvmh03twtw0gySQv9D7shOYB7M3bK_KHYKYYha6aQBaZL-CIZJoekguOjohpPMnMGb_JqiazZR3IJD45RJLf-pLeliPnCVn-jkzI5w3XM8kXCY_g4vT94mRatO8oFI7T8bqoFfduTCNtz0jYipfO0xGzMjDhfF36yEdMHQ3piHjsMAgw1viYC5bMsyDZY9htcOFPgFiJ4ZOwVKoKUyvMDZlyHsUFM7Kl5eMBvO32U19nugwd0wwUprMSdKsE7Bm3W8fvCHfTmbYcAOeJjFR6kqj5hBzxARz2eqL9u17za1TYP2d71elTx_ERWdaE1c1PTSM_jmSc0wEcZP1uZHVWMgDZ0_ymQ-Tm7regySaO7tZEn_73yJdwZ7qYz_Tsw9mnZ7BPI5QmAYYOYXf94yY8x1hobV8ky_8D-E4I2Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LaxsxEB7SBEwuoY-0dZu2agj0ks3akna125tJa5yHg6EJ5Cb02sYhWZvWKeTfZyStjbeXQs_SSmJmtDMjffMJ4KBSWYFumyVVrjBBUZwmpXAqyW1RqMKqstS-UHh8kY-u-Ol1dr321FcA7Rs9Parv7o_q6U3AVs7vTbrEiaWT8bEoSo5pQzq3VfoMtjImymItUQ_HK6XnXeENTaOvU7n1ENNZqv8ojTa9DR3GMBbIKW15pOa_3Cp2W4s5_4ZOrvmi4XPYaYJIMoiLfQEbrn4JnXFzTf4K1Agj0VntyGXkDDgkkaqHxKKjQ6JqSyJ7xiOZVeR8Wjky8M8OkeC7fob35cgkoMu_kgH5seJ7JvEyYReuht8vj0dJ85ZCYjjtL5Kq5Nb0qafu6eW64JmxtMe0cCw3tsqs5ySmhrpwTNw3GAgorazPBzNmmRPsNWzWuPC3QLTAECrXFIWO6RXmh6w0Fodzqqczzftd-LKUp5xHygzpUw0cTEYlyEYJ2NOLW_q9hNI0qikJwHk8K5UcBHq-XPR4F_ZaPXEPmFbzPirsn7N9XupT-u89uqx2s4ffknqOHME4p114E_W7GmtpJV0QLc2vOnh-7nYLmm3g6W7M9N1_f_kJOpNvQ3l-cnH2HrapR9MEzNAebC5-PbgPGA4t9Mdg-E_B0Ans
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hormone+Therapy%2C+Mental+Health%2C+and+Quality+of+Life+Among+Transgender+People%3A+A+Systematic+Review&rft.jtitle=Journal+of+the+Endocrine+Society&rft.au=Baker%2C+Kellan+E&rft.au=Wilson%2C+Lisa+M&rft.au=Sharma%2C+Ritu&rft.au=Dukhanin%2C+Vadim&rft.date=2021-04-01&rft.pub=Oxford+University+Press&rft.issn=2472-1972&rft.eissn=2472-1972&rft.volume=5&rft.issue=4&rft_id=info:doi/10.1210%2Fjendso%2Fbvab011&rft.externalDocID=A775446704
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2472-1972&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2472-1972&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2472-1972&client=summon